00586nas a2200133   4500008004100000245010000041210006900141260002200210653002100232653003200253100002100285700001700306856012900323       2009                        eng d00aMidlife opportunities: Firm age and the value of isomorphic alliance strategies in biotech IPOs0 aMidlife opportunities Firm age and the value of isomorphic allia  aChicago, ILc200910aEntrepreneurship10aStrategy & Entrepreneurship1 aKhoury, Theodore1 aDeeds, David  u/biblio/midlife-opportunities-firm-age-and-value-isomorphic-alliance-strategies-biotech-ipos00495nas a2200133   4500008004100000245005700041210005300098260002600151653002100177653003200198100002100230700001700251856009300268       2006                        eng d00aStrategic isomorphism, legitimacy & IPO performance.0 aStrategic isomorphism legitimacy IPO performance  aPittsburgh, PA.c200610aEntrepreneurship10aStrategy & Entrepreneurship1 aKhoury, Theodore1 aDeeds, David  u/biblio/strategic-isomorphism-legitimacy-ipo-performance